The Compounding Loophole
Now that we've gone over the pharmacology of the GLP-1 agonists, let's get back to the economics.
Last time, we asked - how will the economy handle a $12,000/year drug that everyone wants?
Now we have an answer: the compounding loophole.
You May Also Like

TFTC: A Bitcoin Podcast
Marty Bent

Bitcoin Audible
Guy Swann

CISO Insights: Voices in Cybersecurity
CISO Marketplace

Breitband
Deutschlandfunk Kultur

Streamlined Solopreneur: Tips to Help Small Business Owners Grow Without Burnout
Joe Casabona, Productivity & Tech Coach for Solopreneurs

a16z Show
Andreessen Horowitz

Mark Tilbury
Mark Tilbury Fan

ChatGPT - Sol Good Shorts
Sol Good Network

Theo - t3․gg
Theo - t3․gg

科技工作講 Tech Job N Talk
Tech Job N Talk 科技工作講
Community discussion